Prosecution Insights
Last updated: October 04, 2026
Application No. 18/681,608

METHOD FOR PRODUCING QUANTUM DOT

Non-Final OA §102§112
Filed
Feb 06, 2024
Priority
Aug 27, 2021 — JP 2021-138959 +2 more
Examiner
GODENSCHWAGER, PETER F
Art Unit
Tech Center
Assignee
Nippon Chemical Industrial Co., Ltd.
OA Round
1 (Non-Final)
68%
Grant Probability
Favorable
1-2
OA Rounds
4m
Est. Remaining
86%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
702 granted / 1032 resolved
+8.0% vs TC avg
Strong +18% interview lift
Without
With
+17.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
29 currently pending
Career history
1055
Total Applications
across all art units

Statute-Specific Performance

§101
2.1%
-37.9% vs TC avg
§103
45.6%
+5.6% vs TC avg
§102
19.0%
-21.0% vs TC avg
§112
23.5%
-16.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1032 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Priority Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Claim Objections Claim 1 is objected to because of the following informalities: In claim 1, line 3, there is an article missing before “In-P based one.” It is recommended to add either “an” or “the” as appropriate. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 10 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The parentheses in claim 10 render in the claim indefinite as it is not clear if the limitations within the parentheses are required. For purposes of further examination the limitations within the parentheses are interpreted as being required. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-10 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Yang et al. (US Pub. No. 2020/0407631). Regarding Claims 1-2: Yang et al. teaches a method of producing a core-shell quantum dot comprising coating an InP based core with a coating compound in the presence of an amine such as hexylamine (monohexylamine) ([0048]-[0050], [0166], [0172]). Regarding Claims 3-5: Yang et al. teaches the coating compound is compound from a zinc source including a zinc halide such as zinc fluoride ([0166]-[0169] and [0176). Regarding Claim 6: Yang et al. teaches the coating compound as ZnSe (Fig. 1 and [0128]). Regarding Claims 7-10: Claims 7-10 are product by process claims with regards to how the InP core was made in the method of claim 1. “[E]ven though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process.” In re Thorpe, 777 F.2d 695, 698, 227 USPQ 964, 966 (Fed. Cir. 1985) [See MPEP 2113]. However, should Applicant amend the claims such that the production of the InP-based core is not product-by-process, the claims 7-10 are provisionally rejected as follows: Yang et al. teaches the InP core is produced by reaction of tris(trimethylsilyl)phosphine (a compound of chemical formula 1 wherein R is methyl), indium acetate to form a precursor and further reacting the InP precursor with a GaCl3-trioctylphosphine solution (elemental source of Ga) (Example 1, [0280], and Fig. 1). Yang et al. teaches that the InP precursor is formed by a reaction at 120 °C and further reaction at greater than 180 °C and les than 280 °C ([0164] and Example 1, [0280]). Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to PETER F GODENSCHWAGER whose telephone number is (571)270-3302. The examiner can normally be reached 8:30-5:00, M-F EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mark Eashoo can be reached at 571-272-1197. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PETER F GODENSCHWAGER/Primary Examiner, Art Unit 1767 June 1, 2026
Read full office action

Prosecution Timeline

Feb 06, 2024
Application Filed
Feb 06, 2024
Response after Non-Final Action
Jun 04, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12738482
ELECTROACTIVE MATERIALS FOR METAL-ION BATTERIES
2y 2m to grant Granted Sep 15, 2026
Patent 12729481
COMPOSITION CONTAINING FIRST TREATMENT AGENT FOR SYNTHETIC FIBER, METHOD FOR PREPARING DILUTED SOLUTION OF TREATMENT AGENT FOR SYNTHETIC FIBER, METHOD FOR TREATING SYNTHETIC FIBER, METHOD FOR PRODUCING SYNTHETIC FIBER, AND METHOD FOR PRODUCING SHORT FIBER
2y 4m to grant Granted Sep 08, 2026
Patent 12716028
SUCCINIC ANHYDRIDE-DERIVED POLYESTERS AS CORROSION INHIBITORS
4y 0m to grant Granted Aug 25, 2026
Patent 12716024
Non-Linear Optical Materials Containing High Boiling Point Solvents, and Methods of Efficiently Poling the Same
3y 8m to grant Granted Aug 25, 2026
Patent 12703631
METHOD OF PRODUCING LITHIUM SULFIDE WITHOUT USING HYDROGEN SULFIDE GAS
2y 9m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
68%
Grant Probability
86%
With Interview (+17.7%)
3y 0m (~4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1032 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month